新聞/Reuters/ProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCPProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCPRefinitiv閱讀少於1分鐘PRQRProQR Therapeutics NV PRQR:PROQR ANNOUNCES CTA SUBMISSION FOR PHASE 1 STUDY OF AX-0810 TARGETING NTCPReuters歐洲美國股票荷蘭股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html顯示更多登入或建立一個永久免費帳戶來閱讀此新聞讓我們開始吧
